Brighthouse Financial, Inc. BHF 深 沪
等待开盘 03-26 09:30:00 美东时间
60.54
+0.280
+0.46%
华盛通- 最 高60.55
- 今 开60.00
- 成交量 44.87万股
- 最 低 59.985
- 昨 收 60.26
- 总市值 34.62亿
- 52周最高 66.33
- 市盈率 静 10.60
- 换手率 0.78%
- 52周最低 42.07
- 委 比 47.93%
- 总股本 5718.41万
- 历史最高 67.55
- 量 比 0.70
- 振 幅 0.94%
- 历史最低 12.05
- 每 手 1
- 风险率 7.03%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多财报速睇 | Brighthouse Financial, Inc. 2025财年年度营收67.66亿美元，同比增长43.2%；归母净利润3.31亿美元，同比增长15.7%
华盛资讯2月25日讯，Brighthouse Financial, Inc.公布2025财年年度业绩，公司年度营收67.66亿美元，同比增长43.2%，归母净利润3.31亿美元，同比增长15.7%。
02-25 08:02
财报速睇 | Brighthouse Financial, Inc. 2025财年Q4营收16.89亿美元，同比增长40.2%；归母净利润1.12亿美元，同比下滑82.7%
华盛资讯2月24日讯，Brighthouse Financial, Inc.公布2025财年Q4业绩，公司Q4营收16.89亿美元，同比增长40.2%，归母净利润1.12亿美元，同比下滑82.7%。
02-24 06:35
Brighthouse Financial Likely To Report Higher Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Brighthouse Financial, Inc. (NASDAQ:BHF) will release earnings results for its ...
02-23 22:20
Brighthouse Financial Shareholders Approve $4.1B Proposed Acquisition By Aquarian Capital
Brighthouse Financial, Inc. ("Brighthouse Financial" or the "company") (NASDAQ:BHF) announced that at a special meeting of stockholders held earlier today, its common stockholders voted to adopt the previously announced
02-12 21:26
美股大行评级 | 潜在涨幅197.4%！奥麦罗制药获HC Wainwright升目标价至40美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持奥麦罗制药"买入"评级，目标价从20美元升至40美元；HC Wainwright & Co.：维持Cullinan Therapeutics"买入"评级，目标价从26美元升至27美元
01-09 20:22
Barclays Downgrades Brighthouse Finl to Equal-Weight, Maintains Price Target to $65
Barclays analyst Alex Scott downgrades Brighthouse Finl (NASDAQ:BHF) from Overweight to Equal-Weight and maintains the price target from $65 to $65.
01-08 21:36
Brighthouse Financial, Inc. US0 mil declares $0.289 dividend
Brighthouse Financial, Inc. US0 mil (BHFAM) declares $0.289/share quarterly dividend, in line with previous. Forward yield 9.93% Payable Dec. 26; for shareholders of record Dec. 10; ex-div Dec. 10. Se...
2025-11-17 21:08
Raymond James Downgrades Brighthouse Finl to Market Perform
Raymond James analyst Wilma Burdis downgrades Brighthouse Finl (NASDAQ:BHF) from Strong Buy to Market Perform.
2025-11-12 19:15
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
2025-11-10 17:17
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
2025-11-10 10:22
